I agree that this site is using cookies. You can find further informations here.
X
Fayette, Jérôme
171  results:
Search for persons X
?
1

Cetuximab versus methotrexate in first-line treatment of ol..:

Guigay, Joël ; Ortholan, Cécile ; Vansteene, Damien...
The Lancet Healthy Longevity.  5 (2024)  3 - p. e182-e193 , 2024
Link: https://doi.org/10.1016/..
 
?
2

La cancérologie en Guyane : un défi à gagner:

Droz, Jean-Pierre ; Couppié, Pierre ; Fayette, Jérôme
Bulletin du Cancer.  111 (2024)  6 - p. 597-607 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Outcomes in biomarker-selected subgroups from the KESTREL s..:

Seiwert, Tanguy Y. ; Wildsmith, Sophie ; Fayette, Jérôme...
Cancer Immunology, Immunotherapy.  73 (2024)  4 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Adapted EXTREME regimen in the first-line treatment of fit,..:

Guigay, Joël ; Le Caer, Hervé ; Ferrand, François-Régis...
The Lancet Healthy Longevity.  5 (2024)  6 - p. e392-e405 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Survival of bronchopulmonary cancers according to radon exp..:

Dessemon, Juliette ; Perol, Olivia ; Chauvel, Cécile...
Frontiers in Public Health.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

Uncovering immune checkpoint heterogeneity in oral squamous..:

Le Meitour, Yannick ; Foy, Jean-Philippe ; Guinand, Mathilde...
Oral Oncology.  149 (2024)  - p. 106680 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Comparison between exclusive (chemo)radiation and surgery o..:

Gauduchon, Coauthor(s) Thibault ; Dalban, Cécile ; Philippe, Zrounba...
Oral Oncology Reports.  6 (2023)  - p. 100042 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy of second-line chemotherapy or immune checkpoint i..:

Vienne, Agathe ; Collet, Laetitia ; Chevalier, Thomas...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
9

CTIM-32. A PARALLEL COHORT PHASE 2 STUDY OF REGORAFENIB PLU..:

Simonelli, Matteo ; Caccese, Mario ; Larrieu-Ciron, Delphine...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v69-v70 , 2023
Link: https://doi.org/10.1093/..
 
?
10

Randomized phase II study of preoperative afatinib in untre..:

Marret, Grégoire ; Temam, Stéphane ; Kamal, Maud...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
11

NISCAHN: a phase II trial of nivolumab in patients with sal..:

Fayette, Jérôme ; Even, Caroline ; Digue, Laurence...
BMJ Oncology.  2 (2023)  1 - p. e000065 , 2023
Link: https://doi.org/10.1136/..
 
?
12

Occupational asbestos exposure and survival among lung canc..:

Noelle, Hugo ; Pérol, Olivia ; Pérol, Maurice...
Lung Cancer.  179 (2023)  - p. 107182 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Tumor Mutational Burden as a Predictor of Survival with Dur..:

Wildsmith, Sophie ; Li, Weimin ; Wu, Song...
Clinical Cancer Research.  29 (2023)  11 - p. 2066-2074 , 2023
Link: https://doi.org/10.1158/..
 
?
14

Long-term Outcomes with Nivolumab as First-line Treatment i..:

Gillison, Maura L ; Blumenschein Jr, George ; Fayette, Jerome...
The Oncologist.  27 (2022)  2 - p. e194-e198 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Addendum: Hyperprogression and impact of tumor growth kinet..:

Karabajakian, Andy ; Garrivier, Thibaut ; Crozes, Carole...
Oncotarget.  13 (2022)  1 - p. 1305-1305 , 2022
Link: https://doi.org/10.18632..
 
1-15